ALLCYTE
DEAD

Serial Number

87781923

Owner

Allcyte GmbH

Attorney

Michael Fedrick

Filing Date

Feb 2, 2018

Add to watchlist:

No watchlists yet
View on USPTO

ALLCYTE Trademark

Serial Number: 87781923 • Registration: 5737307

ALLCYTE is a trademark filed by Allcyte GmbH on February 2, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Allcyte GmbH

Lazarettgasse 14, AKH BT25.3
Vienna A-1090 , AT

Entity Type: 99

Trademark Details

Filing Date

February 2, 2018

Registration Date

April 30, 2019

Published for Opposition

February 12, 2019

Cancellation Date

November 14, 2025

Goods & Services

electric apparatus and instruments for use in laboratories for medical diagnostic purposes, namely, hematology analyzers and single-cell image analysis devices for testing and/or detecting effects of drugs on cells originating from blood or tissues

cell culture apparatus for laboratory use, namely, cell culture dishes for testing and/or detecting effects of drugs on cells originating from blood or tissues; scientific, optical, measuring and monitoring apparatus and instruments, namely, cell sorting apparatus, microscopes, photometers, electric sensors and digital cameras; computers and computer software for analyzing the effects of drugs on cells originating from blood or tissues; computer hardware and computer software for receiving, processing, transmitting, displaying, and interpreting data, for scientific and medical purposes; test microtiter plates

biochemicals and chemicals for use in industry and science; biochemicals and chemical reagents for in vitro laboratory use for scientific purposes, in particular for cell culture, testing and/or detecting effects of drugs on cells originating from blood or tissues; in vitro diagnostic reagents for scientific use; biochemical and chemical reagents for use in medical science, not for medical use; chemical reagents for use in clinical or medical laboratory use; diagnostic reagents for in vitro laboratory use, other than for medical or veterinary purposes

reactants for medical diagnosis; in vitro diagnostic preparations for medical use, namely, in vitro diagnostic assays; diagnostic reagents and tests for medical purposes, namely, diagnostic reagents and test assays used to predict personalized drug treatments

Medical research, pharmaceutical research, and product development; scientific research and industrial research in the field of biotechnology, biochemistry, and biomedical science, and product development services; laboratory research in the field of pharmaceuticals, namely, cell culture, testing and/or detecting effects of drugs on cells originating from blood or tissues; professional consultancy services relating to biotechnology, biochemistry, and biomedical science; contract research services, namely, medical, pharmaceutical, and scientific research for others; computer programming

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 14, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 30, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 12, 2019 NPUB
PUBLISHED FOR OPPOSITION
Feb 12, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 23, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 14, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 13, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 13, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 13, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 10, 2018 CRFA
ASSIGNED TO LIE
Dec 7, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 3, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 1, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jun 1, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jun 1, 2018 CNRT
ASSIGNED TO EXAMINER
May 16, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2018 NWOS
NEW APPLICATION ENTERED
Feb 6, 2018 NWAP